SEC Form 4Coverage since Jun 5, 2026
$ANIP insider trading
Over the last 12 months, Ani Pharmaceuticals insiders reported no purchases and 7 sales totaling $1.3M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $1.3M 7 events
- Events · 12m
- 7 Form 4 filings, grouped
- Insiders · 12m
- 3 distinct reporters
- 10b5-1 share
- 100% pre-arranged plans
Side
Price · $ANIP · 12Mvia TradingView
Top insiders · 12m
CAREY STEPHEN P.SVP & CFO4× · $1.0M
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.2× · $82K
HAUGHEY THOMAS—1× · $162K
All insider trades
7 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | CAREY STEPHEN P.SVP & CFO · O | ▼ Sale | 2,850 | $81.36 | $232K | -1.6% | plan |
| Jul 13, 2026 | Cook MeredithSR. VP, GENERAL COUNSEL & SEC. · O | ▼ Sale | 500 | $81.84 | $41K | -0.6% | plan |
| Jul 2, 2026 | CAREY STEPHEN P.SVP & CFO · O | ▼ Sale | 3,313 | $86 | $285K | -1.8% | plan |
| Jun 29, 2026 | CAREY STEPHEN P.SVP & CFO · O | ▼ Sale | 2,850 | $84.12 | $240K | -1.6% | plan |
| Jun 12, 2026 | Cook MeredithSR. VP, GENERAL COUNSEL & SEC. · O | ▼ Sale | 500 | $82.03 | $41K | -0.6% | plan |
| Jun 8, 2026 | HAUGHEY THOMASD | ▼ Sale | 2,000 | $80.88 | $162K | -4.9% | plan |
| Jun 5, 2026 | CAREY STEPHEN P.SVP & CFO · O | ▼ Sale | 3,312 | $80 | $265K | -1.8% | plan |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $ANIP feed.